Beijing Centergate Technologies (000931.SZ): Registration application for Non-Pravastatin tablets has been accepted.
Zhongguancun (000931.SZ) announcement, the company's subsidiary Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical for short) ...
Beijing Centergate Technologies(000931.SZ) announced that its subsidiary company, Duoduo Pharmaceutical Co., Ltd. (referred to as Duoduo Pharma), recently received a "Notice of Acceptance" issued by the National Medical Products Administration for the registration application of Febuxostat tablets (specifications: 20mg, 40mg). The indication for this application is for the long-term treatment of hyperuricemia in gout patients, and it is not recommended for hyperuricemia without clinical symptoms.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


